Literature DB >> 21123371

Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Mikael Klingeborn1, Brent Race, Kimberly D Meade-White, Rebecca Rosenke, James F Striebel, Bruce Chesebro.   

Abstract

In nature prion diseases are usually transmitted by extracerebral prion infection, but clinical disease results only after invasion of the central nervous system (CNS). Prion protein (PrP), a host-encoded glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein, is necessary for prion infection and disease. Here, we investigated the role of the anchoring of PrP on prion neuroinvasion by studying various inoculation routes in mice expressing either anchored or anchorless PrP. In control mice with anchored PrP, intracerebral or sciatic nerve inoculation resulted in rapid CNS neuroinvasion and clinical disease (154 to 156 days), and after tongue, ocular, intravenous, or intraperitoneal inoculation, CNS neuroinvasion was only slightly slower (193 to 231 days). In contrast, in anchorless PrP mice, these routes resulted in slow and infrequent CNS neuroinvasion. Only intracerebral inoculation caused brain PrPres, a protease-resistant isoform of PrP, and disease in both types of mice. Thus, anchored PrP was an essential component for the rapid neural spread and CNS neuroinvasion of prion infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123371      PMCID: PMC3028874          DOI: 10.1128/JVI.02167-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Scrapie prion protein contains a phosphatidylinositol glycolipid.

Authors:  N Stahl; D R Borchelt; K Hsiao; S B Prusiner
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

2.  Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly.

Authors:  R H Kimberlin; C A Walker
Journal:  J Gen Virol       Date:  1986-02       Impact factor: 3.891

3.  Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.

Authors:  C J Gibbs; A Joy; R Heffner; M Franko; M Miyazaki; D M Asher; J E Parisi; P W Brown; D C Gajdusek
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

4.  Targeting of scrapie lesions and spread of agent via the retino-tectal projection.

Authors:  H Fraser; A G Dickinson
Journal:  Brain Res       Date:  1985-10-28       Impact factor: 3.252

5.  Creutzfeldt-Jakob disease after administration of human growth hormone.

Authors:  J Powell-Jackson; R O Weller; P Kennedy; M A Preece; E M Whitcombe; J Newsom-Davis
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

Review 6.  Transport and targeting of scrapie infectivity and pathology in the optic nerve projections following intraocular infection.

Authors:  J R Scott; H Fraser
Journal:  Prog Clin Biol Res       Date:  1989

7.  Pathogenesis of mouse scrapie: dynamics of vacuolation in brain and spinal cord after intraperitoneal infection.

Authors:  S Cole; R H Kimberlin
Journal:  Neuropathol Appl Neurobiol       Date:  1985 May-Jun       Impact factor: 8.090

8.  Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve.

Authors:  R H Kimberlin; S M Hall; C A Walker
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

9.  Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral.

Authors:  R H Kimberlin; S Cole; C A Walker
Journal:  Microb Pathog       Date:  1987-06       Impact factor: 3.738

10.  The role of the spleen in the neuroinvasion of scrapie in mice.

Authors:  R H Kimberlin; C A Walker
Journal:  Virus Res       Date:  1989-03       Impact factor: 3.303

View more
  34 in total

Review 1.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

Review 2.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 3.  Prions and the potential transmissibility of protein misfolding diseases.

Authors:  Allison Kraus; Bradley R Groveman; Byron Caughey
Journal:  Annu Rev Microbiol       Date:  2013-06-28       Impact factor: 15.500

Review 4.  Transmission of prions within the gut and towards the central nervous system.

Authors:  Gianfranco Natale; Michela Ferrucci; Gloria Lazzeri; Antonio Paparelli; Francesco Fornai
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

5.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

6.  Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

Authors:  A Rangel; B Race; J Striebel; B Chesebro
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

7.  Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.

Authors:  Brent Race; Martin Jeffrey; Gillian McGovern; David Dorward; Bruce Chesebro
Journal:  Prion       Date:  2017-07-31       Impact factor: 3.931

Review 8.  Alzheimer's disease and prion protein.

Authors:  Jiayi Zhou; Bingqian Liu
Journal:  Intractable Rare Dis Res       Date:  2013-05

9.  Seeding plaques in Alzheimer's disease.

Authors:  Marco A M Prado; Gerald Baron
Journal:  J Neurochem       Date:  2012-03       Impact factor: 5.372

10.  Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.

Authors:  Brent Race; Katie Phillips; Allison Kraus; Bruce Chesebro
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.